Listing 1 - 7 of 7 |
Sort by
|
Choose an application
The marine environment is considered one of the most important sources of natural bioactive compounds with extremely rich biodiversity. Marine glycans are remarkable molecules, playing a determinant role in biological processes. Marine сarbohydrate-containing substances have drawn increasing attention in the field of biomedicine for their various biological activities, such as antitumor, antivirus, hypoglycemic, immunomodulatory, and anticoagulant. These compounds obtained from marine sources, such as algae, microbes, and animals, are usually biodegradable and biocompatible, and exhibit biological properties that contribute to the discovery of a wide range of new bioactive substances with special pharmacological properties of interest to medicine. Carbohydrate-based compounds include glycans, glycoproteins, proteoglycans, glycolipids, and low-molecular and complex glycosides of differential origin. Many of the polysaccharides allow for loading lower drug dosages, which may lead to a drastic reduction of the side effects caused by the drugs. In addition, the structure of polysaccharides can be relatively easily modified in order to synthesize derivatives with desirable characteristics for drug delivery. Complexes on the basis of carbohydrates are often prepared to improve their functional properties. In this Special Issue, we seek to contribute to the discussion of various aspects of marine carbohydrate-containing compounds and provide a unique platform for a new concept for their use in medicine in order to continue to facilitate further research in this area.
chitosan-gentamicin conjugate --- antimicrobial --- anti-inflammatory --- scald repair --- sulfated polysaccharides --- galactans --- green seaweed --- NMR --- immunostimulation --- inflammatory mediators --- carrageenan --- lipopolysaccharide --- macromolecular structure --- nonspecific resistance to lipopolysaccharide --- cytokines --- enteric infections --- salmonellosis --- glyceroglycolipid metabolism --- phosphate starvation --- transcriptome --- glyceroglycolipid homeostasis --- chitosan --- polyelectrolyte complex --- cytokine --- nitric oxide --- anti-inflammatory activity --- Ulva pertusa --- polysaccharides --- colitis --- antioxidant --- exopolysaccharide --- structure --- Vibrio alginolyticus --- Epidermist --- chitosan oligosaccharides --- inflammation cytokines --- intestine --- oxidative status --- oxidative stress --- Porphyridium marinum --- high pressure homogenizer --- antibacterial activity --- anti-biofilm activity --- anti-cancer activity --- alginate lyase --- cold-adapted --- exo/endo-type --- Alteromonas portus --- oligosaccharide --- antioxidant activity --- exopolysaccharides --- scandium --- theranostic --- cancer cell lines --- proliferation --- laminarin --- fucoidan --- gastrointestinal tract --- microbiome --- swine --- post-weaning --- antibiotic alternatives --- n/a
Choose an application
This Special Issue explored different topics concerning recent progress in the synthesis and characterization of suitable innovative macromolecular systems, proposed as carriers of specific antimicrobial molecules, to be employed in the biomedical and pharmaceutical fields. Many infectious diseases are induced by omnipresent micro-organisms, including bacteria, viruses, protozoa, fungi, and algae, and, consequently, are very common, accounting for a significant share of the global disease burden. Unfortunately, antimicrobial resistance, adverse effects, and the high cost of antimicrobials are crucial health challenges worldwide. One of the common efforts in addressing this issue lies in improving the existing antimicrobial delivery systems. In this regard, nanoparticles as well as three-dimensional hydrophilic systems represent valuable tools able to ensure excellent performances. Biocompatible polymeric particles, entrapping these bioactive molecules, are capable of releasing them over a desired period of time, thereby decreasing the frequency of their administration. At the same time, these systems are able to protect antimicrobial drugs from degradation, enhancing their bioavailability. This Special Issue serves to highlight and capture the contemporary progress recorded in this field.
film nanocomposite --- essential oil --- supercritical CO2 --- long-term package --- hybrid nanoparticles --- biocompatible polymer --- antimicrobial amphiphiles --- dynamic light scattering --- scanning electron microscopy --- cell viability from counting of colony-forming unities --- antimicrobial activity of nanoparticles --- Escherichia coli --- Staphylococcus aureus --- Candida albicans --- hydrogel --- polyvinyl alcohol --- aliphatic dicarboxylic acids --- sustained release --- linezolid --- equilibrium swelling ratio --- accumulative release --- thermogravimetric analysis --- gram-negative bacteria --- multidrug resistance --- polymer therapeutics --- colistin --- polymyxin B --- nanoliposomes --- MDR-Bacteria --- chitosan --- nanotechnologies --- plant extracts --- agro-food-wastes --- antimicrobial agents --- polymeric nanocarriers --- mixed polymeric micelles --- drug delivery --- antibiotics --- Pluronic F127 --- antimicrobial agent --- polymeric nanomaterial --- self-assembly --- antimicrobial peptide --- silver nanoparticle --- anti-biofilm --- wound healing --- bromelain --- nisin --- bioactivity --- biomedicine --- carrier --- n/a
Choose an application
This book is focused on the existing gap between the theoretical bioactivity of (poly)phenols and their real influence in terms of health, once ingested. Due to this, new studies are needed and some examples of new tendencies are included from in vitro and in vivo models which allow for exploring bioaccessibility, bioavailability, and bioactivity, that need to be developed to understand the actual importance of consuming functional foods, rich in these plant secondary metabolites. Moreover, current new strategies need to be developed to enhance the content of these foods, as well as setting up new formulations rich in bioaccessible and bioavailable compounds. Altogether, it could provide a new perspective in therapy, expanding the use of these natural functional compounds, ingredients, and foods in the clinical frame, reducing the use of synthetic drugs. As a result, the joint contribution of multidisciplinary experts from the areas of food science, health, and nutrition, together with the industrial sector, would help to reach these objectives. Taking this into account, diverse studies have been included in this study, which comprises different strategies to approach these objectives from different, complementary, points of view, ranging from the enrichment of by-products in bioactive compounds, through different agricultural techniques, to the assimilation of these compounds by the human body, both in vitro and in vivo, as well as by clinical studies.
cognitive function --- polyphenols --- flavonoids --- CREB protein --- BDNF --- memory --- fruits and vegetables --- cerebral blood flow --- polydatin --- resveratrol --- urate crystals --- pyrophosphate crystals --- crystal-induced inflammation --- dietary intervention --- maqui-citrus juice --- flavanones --- urinary excretion --- UHPLC-ESI-QqQ-MS/MS --- obesity --- Hibiscus sabdariffa --- Lippia citriodora --- olive --- salinity --- osmolytes --- adaptation --- secondary metabolism --- plant growth promoting rhizobacteria (PGPR) --- net photosynthesis --- oleuropein --- water use efficiency (WUE) --- phenolic compounds --- HPLC-DAD --- fluorescence detection --- flavan-3-ols --- procyanidins --- ORAC --- (+)-catechin --- (−)-epicatechin --- dark chocolate --- cranberry --- periodontal diseases --- dental biofilm --- antibacterial activity --- anti-biofilm activity --- F. nucleatum --- P. gingivalis --- A. actinomycetemcomitans --- n/a --- (poly)phenols --- bioactivity --- bioavailability --- inflammation --- secondary metabolites --- antibacterial --- antioxidant --- diet --- fruit --- vegetables
Choose an application
The rapid increase in the emergence of antibiotic-resistant bacterial strains, combined with a dwindling rate of discovery of novel antibiotic molecules, has created an alarming issue worldwide. Although the occurrence of resistance in microbes is a natural process, the overuse of antibiotics is known to increase the rate of resistance evolution. Under antibiotic treatment, susceptible bacteria inevitably die, while resistant microorganisms proliferate under reduced competition. Therefore, the out-of-control use of antibiotics eliminates drug-susceptible species that would naturally limit the expansion of resistant species. In addition, the ability of many microbial species to grow as a biofilm has further complicated the treatment of infections with conventional antibiotics. A number of corrective measures are currently being explored to reverse or slow antibiotic resistance evolution, Among which one of the most promising solutions is the development of polymer-based antimicrobial compounds. In this Special Issue, different polymer systems able to prevent or treat biofilm formation, including cationic polymers, antibacterial peptide-mimetic polymers, polymers or composites able to load and release bioactive molecules, and antifouling polymers able to repel microbes by physical or chemical mechanisms are reported. Their applications in the design and fabrication of medical devices, in food packaging, and as drug carriers is investigated.
imidization --- antifouling materials --- n/a --- UV-induced polymerization --- 2-hydroxyethyl methacrylate --- additive manufacturing --- antimicrobial resistance --- biofilm --- antibacterial peptides --- ocular infections --- food shelf-life --- hemolytic activity --- polyamide 11 --- coatings from nanoparticles --- polymeric surfaces --- microbial biofilm --- ?-chymotrypsin --- antimicrobial properties --- linear low-density polyethylene --- drug delivery systems --- ESKAPE pathogens --- halictine --- composites --- foodborne pathogens --- layered double hydroxides --- cuprous oxide nanoparticles --- multifunctional hybrid systems --- microbicidal coatings --- adhesives --- acrylates --- quaternization --- polymeric biocide --- biocompatible polymer --- surface functionalization --- sol-gel preparation --- antifouling --- antimicrobial peptides --- polymerizable quaternary ammonium salts --- antibiofilm activity --- polymeric films --- antibacterial activity --- bionanocomposites --- cationic polymers --- Escherichia coli --- antibacterial --- biofilm methods --- drug delivery --- circular dichroism --- coatings wettability --- antimicrobial polymers --- fluorescence --- Staphylococcus aureus --- biofilm analysis --- polyethylene glycol --- copolymerization --- dynamic light scattering --- physiological salt --- copper paint --- medical device-related infections --- olive mill wastewater --- Acinetobacter baumannii --- anti-biofilm surface --- additives --- periodontitis --- periodontal biofilms --- antimicrobial peptide --- segmented polyurethanes --- plastic materials --- biocompatible systems --- bactericidal coatings --- bacteria viability --- wound dressings --- ordered mesoporous silica --- quaternary ammonium --- multidrug-resistant --- antimicrobial polymer --- biofilm devices --- biofilm on contact lenses --- water disinfection --- amorphous materials --- polymers --- infrared spectroscopy --- quaternary ammonium salts --- lipopeptides --- antibacterial properties --- thermal stability --- proteinase --- active packaging --- antibacterial polymers --- anti-biofilm surfaces --- 3D printing --- drug carrier --- persister cells
Choose an application
The books described marine glycoconjugates. Two articles concern microalgal metabolites such as steroid and sphingoid glycoconjugates, and a glycoprotein from a sea cucumber with interesting biological activities, respectively. One article discusses the fatty acid composition and thermotropic behavior of glycolipids and other membrane lipids of green macrophyte Ulva lactuca. Three articles cover lectin subjects. One review article analyzes perspectives of marine and freshwater lectins’ application in experimental oncology and the therapy of oncological diseases; another article describes the use of a sponge lectin in the construction of a recombinant virus. The third article concerns the function of the immunity of a lectin in producing this compound crinoid. Two articles concern steroid glycosides from star?sh, and two others concern triterpene glycosides from sea cucumbers. One article describes the e?ect of a glycosaminoglycan from the sea cucumber Apostichopus japonicus on hyperglycemia in the liver of insulin-resistant mice. One article concerns the isolation of 10 new triterpene glycosides from a fungus associated with a sea cucumber. The article by Dworaczek et al. characterizes the O-speci?c polysaccharide (O-antigen) of a bacterial pathogen of common carp by chemical and immunochemical methods. In total, the Special Issue comprises14 articles, including the editorial and two reviews.
n/a --- functions --- feather star --- Aeromonas --- glycosylceramides --- sghC1qDC --- O-antigen --- colony formation --- Bcl-2 proteins --- phospholipids --- sterol glycoconjugates --- Anthenea aspera --- glycosides --- Anneissia japonica --- cancer therapy --- secondary metabolites --- Echinoderm --- Apostichopus japonicus --- microalgae --- urease activity --- triterpene glycosides --- cytotoxic activity --- Alexandrium minutum --- Acremonium striatisporum --- betaine lipid --- signal transduction --- thermal adaptation --- Psolus fabricii --- O-polysaccharide --- oncolytic vaccinia virus --- N-Acetyllactosamine (LacNAc) --- l-perosamine --- differential scanning calorimetry --- Lethasterias fusca --- polyhydroxysteroids --- AMPK --- glycoprotein --- NMR spectroscopy --- glucose metabolism --- anti-biofilm activity --- ERK --- fish pathogen --- marine antiproliferative compounds --- lectin --- immunospecificity --- in vivo studies --- apoptosis --- distribution --- steroidal glycosides --- natural products --- biological activities --- Aphrocallistes vastus lectin --- marine fungi --- cell adhesion --- in vitro studies --- mass spectrometry --- psolusosides --- starfish --- sea cucumber --- glycosaminoglycan --- lipopolysaccharide (LPS) --- glycolipids --- fatty acids --- structures --- Akt --- diterpene glycosides --- body components --- structure --- mitophagy --- marine lectins --- crinoid --- cancer --- asterosaponins
Choose an application
In recent years, peptides have received increased interest from the pharmaceutical industry. The high potency, specificity, and safety profile are the main strengths of bioactive peptides as new and promising therapies that may fill the gap between small molecules and protein drugs. These positive attributes have renewed interest in the discovery, optimization, and development of peptides as pharmacological therapy. Among bioactive peptides, those released from food sources have acquired importance as nutraceutical and active components in functional foods because they possess regulatory functions that can lead to health benefits. This Special Issue covers a selection of recent research papers and reviews in the field of bioactive peptides. It covers all aspects of peptide research in relation to health promotion. In particular, it emphasizes current knowledge and research trends concerning bioactive peptides, including identification and quantification of peptides from new sources, methods for their production and purification, structure–function relationships, mechanisms of action, in vitro and in vivo assays for the evaluation of their bioactivity, physiological evidence to support health benefits, and peptide stability and bioavailability. Papers regarding the development of new drugs, functional foods, or nutraceuticals based on bioactive peptides were also considered.
antihypertensive peptides --- functional food --- food-derived --- fermentation --- Chlorella sorokiniana --- in silico --- BIOPEP-UWM database --- proteomics --- bioactive peptides --- nano liquid chromatography tandem mass spectrometry (nanoLC–nanoESI MS/MS) --- apolipoprotein E --- amyloid fibrils --- Alzheimer’s disease --- Αβ oligomer --- amyloid --- Aβ peptide --- glioma --- platelets --- antiproliferative assay --- conjugation --- docetaxel --- doxorubicin --- extra domain B --- fibronectin --- Fmoc/tBu --- peptide–drug conjugate --- prostate cancer --- solid-phase synthesis --- targeting --- acrylamide --- enteric nervous system --- galanin --- pig --- stomach --- formyl peptide receptors --- ligands --- diseases --- polymicrobial biofilms --- intragenic antimicrobial peptide --- Hs02 --- Pseudomonas aeruginosa --- Staphylococcus aureus --- osteostatin --- arthritis --- inflammation --- immune response --- cartilage destruction --- bone erosion --- collagen --- hydrolysis --- enzyme --- molecular weight --- sheepskin --- NF-κB --- dry-cured pork ham --- angiotensin I converting enzyme --- endothelial dysfunction --- molecular blind docking --- Lactoferricin B (Lfcin B) --- Histatin-5 --- antimicrobial peptides (AMPs) --- antifungal activity --- proteome microarray --- synergy --- temporin --- MRSA --- antimicrobial peptide --- human keratinocytes --- pseudin-2 --- antisepsis, peptide antibiotics --- neurotensin --- asthma --- T cells --- In situ tetramer staining --- MHC tetramer --- antigen-specific --- confocal microscopy --- fresh tissue --- velvet antler --- alcalase hydrolysate --- antioxidant peptide --- protection ability --- oxidative stress --- Crassostrea angulata --- pidotimod --- CXCR3 --- monocyte --- migration --- PI3K/Akt pathway --- T cell --- immunomodulant --- host defense peptides --- membrane activity --- copper --- piscidins --- Clostridioides difficile --- prolactin-releasing peptide --- GPR10 --- RF-amide peptides --- food intake regulation --- energy expenditure --- neuroprotection --- signaling --- gender differences --- dyslipidemia --- obesity --- hyperglycemia --- pulmonary emphysema --- endothelial progenitor cells --- angiogenic precursor cells --- pegylated glucagon-like peptide 1 --- and endothelial regeneration --- miiuy croaker (Miichthys miiuy) --- swim bladder --- FPYLRH --- antioxidant activity --- cytoprotective effect --- antimicrobial peptides --- antimicrobial resistance --- AMP identification and design --- biosynthesis --- mode of action --- physico-chemical properties --- therapeutic potential --- insects --- Cecropins --- Cec-analogs --- MDR infectious diseases --- airway inflammation --- non-atopic asthma --- hybrid peptide --- pro-inflammatory cytokines --- sPLA2 --- MDA --- database --- proteolysis --- SMILES code --- foods --- nutrition --- chronic diseases --- nutraceuticals --- peptide vaccine --- immune checkpoint inhibitor --- humanized mouse --- cancer antigen --- immune suppression --- vasoactive intestinal peptide --- VPAC1 receptor --- VPAC2 receptor --- rheumatic diseases --- inflammatory bowel disease --- central nervous system diseases --- type 1 diabetes --- Sjögren’s syndrome --- biomarkers --- human antimicrobial peptides --- defensins --- cathelicidins --- anti-inflammatory --- pro-inflammatory --- peptide --- combinatorial library --- library design --- screening --- mutagenesis --- prolyl-hydroxyproline (Pro-Hyp) --- hydroxyprolyl-glycine (Hyp-Gly) --- collagen peptide --- fibroblasts --- fetal bovine serum (FBS) --- AMD --- CNV --- VEGFR1 --- multimeric peptides --- oral delivery --- colorectal cancer --- cancer stem cells --- chemoprevention --- bioactive peptide --- lunasin --- ACE-inhibitory activity --- whey peptides --- molecular docking --- hypertension --- antibiotic resistance --- cystic fibrosis --- cryptides --- anti-biofilm peptides --- synergistic effects --- n/a --- nano liquid chromatography tandem mass spectrometry (nanoLC-nanoESI MS/MS) --- Alzheimer's disease --- peptide-drug conjugate --- Sjögren's syndrome
Choose an application
In recent years, peptides have received increased interest from the pharmaceutical industry. The high potency, specificity, and safety profile are the main strengths of bioactive peptides as new and promising therapies that may fill the gap between small molecules and protein drugs. These positive attributes have renewed interest in the discovery, optimization, and development of peptides as pharmacological therapy. Among bioactive peptides, those released from food sources have acquired importance as nutraceutical and active components in functional foods because they possess regulatory functions that can lead to health benefits. This Special Issue covers a selection of recent research papers and reviews in the field of bioactive peptides. It covers all aspects of peptide research in relation to health promotion. In particular, it emphasizes current knowledge and research trends concerning bioactive peptides, including identification and quantification of peptides from new sources, methods for their production and purification, structure–function relationships, mechanisms of action, in vitro and in vivo assays for the evaluation of their bioactivity, physiological evidence to support health benefits, and peptide stability and bioavailability. Papers regarding the development of new drugs, functional foods, or nutraceuticals based on bioactive peptides were also considered.
antihypertensive peptides --- functional food --- food-derived --- fermentation --- Chlorella sorokiniana --- in silico --- BIOPEP-UWM database --- proteomics --- bioactive peptides --- nano liquid chromatography tandem mass spectrometry (nanoLC–nanoESI MS/MS) --- apolipoprotein E --- amyloid fibrils --- Alzheimer’s disease --- Αβ oligomer --- amyloid --- Aβ peptide --- glioma --- platelets --- antiproliferative assay --- conjugation --- docetaxel --- doxorubicin --- extra domain B --- fibronectin --- Fmoc/tBu --- peptide–drug conjugate --- prostate cancer --- solid-phase synthesis --- targeting --- acrylamide --- enteric nervous system --- galanin --- pig --- stomach --- formyl peptide receptors --- ligands --- diseases --- polymicrobial biofilms --- intragenic antimicrobial peptide --- Hs02 --- Pseudomonas aeruginosa --- Staphylococcus aureus --- osteostatin --- arthritis --- inflammation --- immune response --- cartilage destruction --- bone erosion --- collagen --- hydrolysis --- enzyme --- molecular weight --- sheepskin --- NF-κB --- dry-cured pork ham --- angiotensin I converting enzyme --- endothelial dysfunction --- molecular blind docking --- Lactoferricin B (Lfcin B) --- Histatin-5 --- antimicrobial peptides (AMPs) --- antifungal activity --- proteome microarray --- synergy --- temporin --- MRSA --- antimicrobial peptide --- human keratinocytes --- pseudin-2 --- antisepsis, peptide antibiotics --- neurotensin --- asthma --- T cells --- In situ tetramer staining --- MHC tetramer --- antigen-specific --- confocal microscopy --- fresh tissue --- velvet antler --- alcalase hydrolysate --- antioxidant peptide --- protection ability --- oxidative stress --- Crassostrea angulata --- pidotimod --- CXCR3 --- monocyte --- migration --- PI3K/Akt pathway --- T cell --- immunomodulant --- host defense peptides --- membrane activity --- copper --- piscidins --- Clostridioides difficile --- prolactin-releasing peptide --- GPR10 --- RF-amide peptides --- food intake regulation --- energy expenditure --- neuroprotection --- signaling --- gender differences --- dyslipidemia --- obesity --- hyperglycemia --- pulmonary emphysema --- endothelial progenitor cells --- angiogenic precursor cells --- pegylated glucagon-like peptide 1 --- and endothelial regeneration --- miiuy croaker (Miichthys miiuy) --- swim bladder --- FPYLRH --- antioxidant activity --- cytoprotective effect --- antimicrobial peptides --- antimicrobial resistance --- AMP identification and design --- biosynthesis --- mode of action --- physico-chemical properties --- therapeutic potential --- insects --- Cecropins --- Cec-analogs --- MDR infectious diseases --- airway inflammation --- non-atopic asthma --- hybrid peptide --- pro-inflammatory cytokines --- sPLA2 --- MDA --- database --- proteolysis --- SMILES code --- foods --- nutrition --- chronic diseases --- nutraceuticals --- peptide vaccine --- immune checkpoint inhibitor --- humanized mouse --- cancer antigen --- immune suppression --- vasoactive intestinal peptide --- VPAC1 receptor --- VPAC2 receptor --- rheumatic diseases --- inflammatory bowel disease --- central nervous system diseases --- type 1 diabetes --- Sjögren’s syndrome --- biomarkers --- human antimicrobial peptides --- defensins --- cathelicidins --- anti-inflammatory --- pro-inflammatory --- peptide --- combinatorial library --- library design --- screening --- mutagenesis --- prolyl-hydroxyproline (Pro-Hyp) --- hydroxyprolyl-glycine (Hyp-Gly) --- collagen peptide --- fibroblasts --- fetal bovine serum (FBS) --- AMD --- CNV --- VEGFR1 --- multimeric peptides --- oral delivery --- colorectal cancer --- cancer stem cells --- chemoprevention --- bioactive peptide --- lunasin --- ACE-inhibitory activity --- whey peptides --- molecular docking --- hypertension --- antibiotic resistance --- cystic fibrosis --- cryptides --- anti-biofilm peptides --- synergistic effects --- n/a --- nano liquid chromatography tandem mass spectrometry (nanoLC-nanoESI MS/MS) --- Alzheimer's disease --- peptide-drug conjugate --- Sjögren's syndrome
Listing 1 - 7 of 7 |
Sort by
|